Pharmaceutical company CanSino BIO has recommended a booster for its COVID-19 single-dose vaccine six months after the first application

Last Friday, the first 200,000 CanSino BIO formulas, the Chinese single-dose vaccine, arrived in Argentina. In the last hours, the pharmacist based in Tianjin, China, recommended this Sunday to apply a booster of its vaccine against covid-19 six months after receiving the first dose, after a study conducted by the company.

“The biopharmaceutical company CanSino Biologics (CanSino BIO) reports that it has obtained specific and compelling new results that neutralizing antibody levels in your COVID vaccine remain high – nearly 70% – in people, six months after being vaccinated with this unit dose“the pharmaceutical company said in a statement.

He also pointed out that a second dose of the vaccine increases the levels of neutralizing antibodies by eight.

“A second application of the CanSino vaccine offers better protection to those who received it, and it is safe”, The specified document.

The company reported that Studies have shown that for those who received two injections of inactivated virus vaccines, a third application of the biologic as a booster produced antibody levels “several times higher than the products per application.” What booster from other doses of inactivated virus vaccines”.

And reiterated that its vaccine is “very safe which offers lasting protection – over six months – prevents hospitalization and death in 90% of people to whom it is applied.””.

I remembered that continues phase III of its biological clinical trials in Mexico, involving 15,000 Mexican volunteers, and as soon as the final results are obtained, modifications related to the number of doses of the vaccine will be made.

The arrival of these formulations in Argentina took place later for government to approve emergency use of CanSino vaccine and agreed with this Chinese laboratory to send 5.4 million doses, this morning the first shipment of 200,000 units arrived in the country.

Qatar Airways flight QR8157 landed at 2:20 p.m. Friday at Ezeiza Airport with the first doses that will be used to continue the strong progress of the Strategic Vaccination Plan to fight COVID-19.

This is the first game of a contract which envisages the shipment of 5.4 million doses during this year, as anticipated a few days ago during a press conference by the Minister of Health of the Nation, Carla Vizzotti.

This serum is a single application and has become the third vaccine developed by China, after Sinovac and Sinopharm.

CanSino biological vaccine has the same technology as the Ebola vaccine, which is made up of viral vectors (genetic material), and the viruses used as vehicles are attenuated.

Hence, they cannot cause COVID-19 disease. Upon receipt of the inoculant, the viral vector will produce hundreds of replicas of the antigen so that in this way the immune system generates a response with neutralizing antibodies after 14 days.

With information from the EFE

KEEP READING: